Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
A UHN-led portable testing tool is providing doctors with a better way to track the progression of glaucoma
Every Saturday morning, Dennis Graff makes himself comfortable in his favourite lounge chair and dons a headset. Although it might look like he's getting ready for a video-gaming session, the 75-year-old Toronto resident is actually testing his vision.
Graff, who previously had surgery to treat both glaucoma and cataracts, is part of a two-year-long study testing the latest tool in eye disease monitoring technology.
"I'm game to help with something that might help others," he says. The system, which consists of a smartphone, a virtual reality headset, a remote clicker and advanced control and analysis software, is the brainchild of Donald K. Johnson Eye Institute scientist Professor Moshe Eizenman. Institute ophthalmologists Drs. Graham Trope and Yvonne Buys assist Prof. Eizenman with patient assessments.
Together, the trio is developing new and better ways to track the progression of the eye disease glaucoma. The innovative tool, called the Toronto Portable Perimeter, or TPP, offers a way for patients in remote parts of Canada, or under-resourced countries around the world, to get access to high-quality vision care.
IMPROVING ON AN IMPERFECT PROCESS
Glaucoma is a disease characterized by the degeneration of the optic nerve connecting the eye to the brain. It progresses slowly, with few symptoms. The best way doctors currently have to track its progression is to ask patients to come to the hospital twice a year for visual field tests. The patient sits in front of a large machine, keeps their eye looking straight ahead and watches lights appearing in their peripheral vision. The patient pushes a button when they see the flashes.
"Patients dislike doing visual field tests. It's one of the most stressful parts of coming to the eye doctor," says Dr. Trope. "It's physiologically unnatural, and a number of patients simply don't do the test well."
Graff says doing the visual field test in the comfort of his own home is a vast improvement over doing them at the hospital.
"The at-home test is just more convenient. I find it more relaxing, too" explains Graff, who has the weekly event marked on his calendar and who has become a bit of a pro when it comes to doing the test at home. "It's very simple."
The TPP system offers more than just convenience. Because the standard, in-office test requires specialized training to administer, there's a cap on the number of patients a hospital can see in a week. That means patients will only have their vision tested twice a year, in many cases, and it's difficult to spot if a person's visual field is deteriorating.
"The evidence indicates that we are missing progression," notes Dr. Trope. The TPP allows patients to do the same test at home, when they want and more often throughout the year. The results of the test are analyzed and sent wirelessly for assessment. It saves patients time, saves money (the TPP is about 40 times cheaper than the standard device) and could allow clinicians to track the disease more efficiently.
So far, the doctors say the results of the study are promising. When the TPP was tested on 150 eyes, it performed just as well as the standard visual field test in terms of measuring how far, and how well, a person can see into their periphery. The TPP was also the clear preference for patients in terms of comfort and ease of use.
BETTER ACCESS IN MORE PLACES
Lower cost and portability make the TPP perfect for glaucoma screening in remote parts of Canada, where patients might have to travel hours to a hospital. It's also beneficial for under-resourced countries, where patients do not have easy access to hospitals and expensive visual field testing devices.
In 2019, the TPP was sent to northern Ontario, travelling as far as Pickle Lake on-board the CNIB Foundation Eye Van, to screen people in remote communities for glaucoma. The device is also being tested in Singapore and Nepal as a screening tool for the early stages of glaucoma. The TPP has the potential to make a huge impact in developing countries like Nepal, says Prof. Eizenman, because of how frequently glaucoma progresses to blindness through lack of available testing.
"If you detect the disease early and track it, you can manage it," he says.
The team has high ambitions for the device, which they say is part of a bigger move to bring health care out of hospitals and into people's homes.
"It really could revolutionize the way visual fields are performed," says Dr. Trope.